Naproxen Sodium (2 x 220 mg) Fasted Comparative Bioavailability Study

NCT03167541 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Test
DRUG: Reference

Sponsor

Reckitt Benckiser Healthcare (UK) Limited

Collaborators

[object Object]